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Shaffo FC, Grodzki AC, Fryer AD, Lein PJ. Mechanisms of organophospho-
rus pesticide toxicity in the context of airway hyperreactivity and asthma. Am J
Physiol Lung Cell Mol Physiol 315: L485–L501, 2018. First published June 28,
2018; doi:10.1152/ajplung.00211.2018.—Numerous epidemiologic studies have
identified an association between occupational exposures to organophosphorus
pesticides (OPs) and asthma or asthmatic symptoms in adults. Emerging epidemi-
ologic data suggest that environmentally relevant levels of OPs may also be linked
to respiratory dysfunction in the general population and that in utero and/or early
life exposures to environmental OPs may increase risk for childhood asthma. In
support of a causal link between OPs and asthma, experimental evidence demon-
strates that occupationally and environmentally relevant OP exposures induce
bronchospasm and airway hyperreactivity in preclinical models. Mechanistic stud-
ies have identified blockade of autoinhibitory M2 muscarinic receptors on para-
sympathetic nerves that innervate airway smooth muscle as one mechanism by
which OPs induce airway hyperreactivity, but significant questions remain regard-
ing the mechanism(s) by which OPs cause neuronal M2 receptor dysfunction and,
more generally, how OPs cause persistent asthma, especially after developmental
exposures. The goals of this review are to 1) summarize current understanding of
OPs in asthma; 2) discuss mechanisms of OP neurotoxicity and immunotoxicity
that warrant consideration in the context of OP-induced airway hyperreactivity and
asthma, specifically, inflammatory responses, oxidative stress, neural plasticity, and
neurogenic inflammation; and 3) identify critical data gaps that need to be
addressed in order to better protect adults and children against the harmful
respiratory effects of low-level OP exposures.
airway hyperreactivity; asthma; eosinophils; macrophages; nerve-immune interac-
tions; neurotoxicity; organophosphorus pesticides
INTRODUCTION
Asthma is a chronic inflammatory lung disease characterized
by episodic and reversible bronchoconstriction, mucus hyper-
secretion, airway inflammation, and airway hyperreactivity
(AHR), all of which interfere with breathing. According to the
US Centers for Disease Control and Prevention, in 2015
approximately 18.4 million adults and 6.2 million children in
the United States had asthma, with 10 people dying from
asthma each day on average (https://www.cdc.gov/asthma/
most_recent_data.htm, accessed April 2018). Asthma preva-
lence and severity have increased markedly over the past two
decades, especially in urban settings (25, 57, 100, 218). Many
hypotheses have been proposed to explain the increased sus-
ceptibility of urban residents to asthma, including exposure to
allergens, air pollution, differences in health care, and stress
(57, 64, 89, 102, 125, 128). An environmental factor associated
with occupational asthma in agriculture (105, 109, 111–113,
115, 155, 248) that is beginning to receive increased attention
in the context of urban asthma (107, 156, 249) is exposure to
organophosphorus pesticides (OPs).
OPs are among the most widely used pesticides worldwide,
and they have been applied extensively in not only agricultural
but also suburban and urban settings to control insects (43).
Although residential uses of OPs have been largely phased out
in the United States and many other countries over the past
decade, OPs are still used heavily in agricultural, industrial,
commercial, and military settings. As a result, OPs are ubiq-
uitous in the human chemosphere, as confirmed by the wide-
spread detection of OP metabolites in urine samples from the
general US population (14, 34, 66). Occupational exposures,
which are mainly associated with the production, distribution,
and application of OPs, occur primarily via dermal absorption,
with more limited exposure via inhalation (72, 106). The
general population is exposed to OPs via ingestion of food and
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water contaminated with OPs and by dermal and inhalational
exposure to pesticide drift and “overspray” (247). The latter is
not an insignificant source of exposure—studies conducted in
communities living near agricultural fields sprayed with OPs
have found extensive OP contamination in the air (98), in
homes (99), and in urine from pregnant women (33) and
children (185) in these communities.
OPs are potent inhibitors of the enzyme acetylcholinesterase
(AChE), which hydrolyzes the neurotransmitter acetylcholine
to terminate cholinergic signaling. The phosphate form of the
insecticide, which may be the parent compound or its active
metabolite depending on the specific pesticide, inhibits AChE
by phosphorylating the serine residue within the catalytic triad
of the enzyme’s active site (179). Inhibition of AChE increases
the amount and residence time of acetylcholine at nicotinic and
muscarinic receptors in target tissues, resulting in cholinergic
overstimulation in the brain and peripheral tissues. Acute OP
poisoning in humans has been extensively documented and
includes both central and peripheral cholinergic effects that
collectively contribute to a clinical toxidrome known as “cho-
linergic crisis” (118). Respiratory failure is the primary cause
of death in cholinergic crisis and is thought to be mediated by
both peripheral and central mechanisms (118). In the periph-
ery, OPs induce bronchoconstriction via cholinergic over-
stimulation of muscarinic receptors on airway smooth muscle
(31). Although it is unclear whether central mechanisms of
respiratory depression are predominantly muscarinic or nico-
tinic, OPs disrupt respiratory control in the brain stem, thereby
triggering central apnea. Although AChE inhibition initiates
the pathogenic mechanisms that ultimately cause respiratory
dysfunction, observations in preclinical models indicate that
central control of breathing often stabilizes before recovery of
AChE activity and recurrent AChE inhibition after the initial
intoxication does not retrigger central apnea (131). These
observations suggest that mechanisms in addition to AChE are
involved in OP-triggered respiratory collapse during cholin-
ergic crisis.
In OP-poisoned humans, respiratory failure can occur during
early or late stages of cholinergic crisis. It is thought that early
respiratory failure, which manifests within the first 24 h after
exposure, is caused by a combination of central nervous system
(CNS) and peripheral (outside the CNS) mechanisms, whereas
late respiratory failure, which occurs 24–96 h after exposure, is
triggered predominantly by peripheral mechanisms (62, 222).
While the mechanisms of delayed respiratory failure are poorly
understood, they likely include delayed neuromuscular dys-
function secondary to desensitization of nicotinic receptors and
increased vascular permeability that leads to severe bronchor-
rhea and inflammation in the lungs (118). In addition to
respiratory failure, other pulmonary complications can arise
and/or persist in patients who survive acute OP intoxication.
For example, persistent asthma has been reported in individu-
als accidentally poisoned by OPs (54).
Although the respiratory effects of acute intoxication with
OPs at levels that cause rapid and profound depression of
AChE activity resulting in cholinergic crisis are well docu-
mented, emerging studies suggest that subchronic or chronic
exposures to OPs at levels that cause minimal depression of
AChE activity may also be associated with adverse respiratory
outcomes, specifically, asthma and asthmatic symptoms. The
evidence for and the mechanisms mediating adverse effects of
low-level OP pesticide exposures, defined as exposures that do
not cause significant AChE inhibition, on lung function are the
focus of this review.
EPIDEMIOLOGIC EVIDENCE OF OP-INDUCED ASTHMA
Early case reports provided the first indication that expo-
sures to OPs at levels that do not cause cholinergic crisis may
trigger asthma or asthmatic symptoms in adults (26, 234).
Subsequent cross-sectional studies of farmers and their fami-
lies, farmworkers, and commercial pesticide applicators in
multiple countries around the world provided further evidence
that occupational exposures to OP pesticides are associated
with decreased lung function, wheezing, and adult-onset
asthma (73, 105, 109–111, 113, 114, 166, 172, 175). Matched
case-control studies of pesticide applicators in India, who were
assessed for blood AChE activity and lung function before and
after spraying season, similarly found significant inverse asso-
ciations between subacute exposures to OPs and key lung
function parameters that persisted for weeks after occupational
exposures ceased (36, 174). Recently published case-control
studies of adolescent pesticide applicators in Egypt concluded
that results were consistent with an association between expo-
sure to the OP chlorpyrifos (CPF; see Table 1 for a list of
common abbreviations for OPs) and reduced lung function
(27). An interesting relationship between OP exposure, allergy,
and asthma has emerged from these studies of occupational OP
exposures: stronger associations are observed between OP
exposures and allergic (atopic) asthma compared with nonal-
lergic (nonatopic) asthma (110, 111).
Although not as extensively studied as occupational OP
exposures, environmental OP exposures have also been asso-
ciated with increased risk of asthma and asthmatic symptoms
in adults and adolescents in the general public (156, 249). More
recently, concerns have grown that children may be particu-
larly vulnerable to effects of environmental OPs on respiratory
health. Growing appreciation of the unique susceptibility of the
developing lung to environmental chemicals (160), coupled
with the observation that children and adolescents dispropor-
tionately contribute to the increased prevalence of asthma
worldwide (25, 236), has prompted investigations of whether
prenatal and early life exposures to environmental contami-
nants, including pesticides, increase individual risk for asthma.
Initial studies demonstrated an association between early life
exposures to pesticides as a general class of environmental
factors and increased risk of asthma and wheeze in children
(201, 202). Subsequent prospective epidemiologic studies have
considered the respiratory impacts of early life exposures to
OPs specifically. Much of the data relevant to this question has
come from The Center for the Health Assessment of Mothers
and Children of Salinas (CHAMACOS), the longest-running
longitudinal birth cohort study of pesticide effects on chil-
dren’s health, which has been studying children in a farm-
Table 1. Pesticide abbreviations
BRP Bromofos
CPF/CPO Chlorpyrifos/chlorpyrifos-oxon
DZN Diazinon
FEN Fenthion
MAL/MO Malathion/malaoxon
PTH/PO Parathion/paraoxon
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worker community in the Salinas Valley of northern California
(66). Data from the CHAMACOS study supports the hypoth-
esis that OP exposures during pregnancy and the first year of
life, as determined by analysis of urinary OP metabolites in
pregnant women and their infants, are associated with respira-
tory symptoms in children at 5 and 7 yr of age (185, 186).
The epidemiologic studies published to date vary consider-
ably with respect to the populations assessed and the methods
used to quantify OP exposure (typically via questionnaire, less
often by quantification of urinary OP metabolites or blood
AChE activity) and to assess respiratory health (self-reported
respiratory symptoms vs. clinically diagnosed respiratory dis-
ease/symptoms vs. spirometry and other functional tests).
These studies face significant challenges in assessing expo-
sure—existing biomarkers of OP exposure (e.g., urinary OP
metabolites and blood AChE activity) reflect only very recent
exposures (197)—and controlling for potentially confounding
coexposures (other classes of pesticides, allergens, livestock,
etc.). Nonetheless, systematic reviews of the published epide-
miologic literature generally support an association between
OP pesticide exposure and respiratory disease, including
asthma. Four of five meta-analyses (3, 58, 107, 248) concluded
that the weight of evidence supports a strong association
between OP exposure and increased risk of asthma and/or
asthma exacerbations. The fifth study (155) concluded that
there was a weak association but noted that because of signif-
icant methodological differences in quantifying pesticide ex-
posure and lung function across studies, further research with
more accurate assessments of OP pesticide exposure and robust
measures of respiratory disease are needed before ruling out an
association between OP exposure and asthma. Better under-
standing of the mechanisms underlying OP effects on respira-
tory function, and the factors (both genetic and environmental)
that modulate respiratory responses to OPs, would further
enable more robust study designs for epidemiologic studies.
EXPERIMENTAL EVIDENCE SUPPORTS CAUSAL LINK
BETWEEN LOW-LEVEL OPS AND ASTHMA
While there are comparatively few preclinical studies of the
respiratory effects of occupationally and environmentally rel-
evant levels of OPs, the available experimental data support the
epidemiologic evidence linking low-level OP exposures to
asthma. Early publications by a research team in Mexico
demonstrated that OPs induce bronchospasm in a variety of
animals when administered at doses that significantly inhibit
AChE activity but do not cause cholinergic crisis (96, 206).
Specifically, intravenous injection of OPs increased total re-
spiratory impedance in calves (96), while intraperitoneal injec-
tion of the OP parathion (PTH) produced a dose-dependent
increase in lung resistance in guinea pigs as measured by
plethysmography (206). Importantly, the latter study also
found that subclinical doses of PTH caused airway hyperre-
sponsiveness to acetylcholine. This effect was replicated in
isolated perfused rabbit lung and prevented by the muscarinic
receptor antagonist atropine (206).
Subsequent research led by US investigators Fryer and Lein
provided more direct evidence of a causal link between low-
level OP exposure and AHR. The preclinical model used by
these investigators was the guinea pig exposed to OPs via
subcutaneous injection to simulate dermal exposure, which is
the predominant route of occupational exposure (72). Admin-
istration via subcutaneous injection also eliminated the poten-
tial confounding effect of reflex bronchoconstriction to irrita-
tion upon inhalation or tracheal instillation of OPs (107). With
this guinea pig model, three structurally distinct diethyl phos-
phorothioate OPs—CPF, diazinon (DZN), and PTH—were
observed to significantly potentiate vagally induced broncho-
constriction measured 24 h after a single injection of the OP
(83, 141). Consistent with the epidemiologic data suggesting
that atopy increases susceptibility to OP-induced asthma (110,
111), antigen sensitization without challenge significantly de-
creased the threshold dose for OP-induced AHR and exacer-
bated OP effects on vagally induced bronchoconstriction in
animals exposed to either CPF (180) or PTH (182). In contrast,
sensitization did not alter DZN-induced AHR (180). Subcuta-
neous exposure to the pyrethroid insecticide permethrin did not
potentiate vagally induced bronchoconstriction in either sensi-
tized or nonsensitized animals (141, 180), indicating that in-
duction of AHR may be common to diethyl phosphorothioate
OP pesticides but is not a generalized toxic effect of all
pesticides. Important questions yet to be addressed are 1)
whether OPs that are not phosphorothioates, which include a
number of widely used OPs, also induce AHR and 2) the
mechanism(s) underlying the differential influence of sensiti-
zation on AHR induced by CPF or PTH versus DZN.
As discussed above, the canonical mechanism of acute OP
toxicity involves AChE inhibition (44); however, several lines
of evidence from the studies conducted by Fryer and Lein
established that OPs induce AHR independent of AChE inhi-
bition. First, direct measurement of AChE activity in the lung,
blood, and brain confirmed that CPF, PTH, and DZN caused
AHR at doses that did not significantly inhibit AChE in these
tissues (83, 141). Second, acute administration of eserine, a
nonorganophosphate cholinesterase inhibitor, at a dose that
significantly inhibited AChE did not potentiate vagally induced
bronchoconstriction (83). Third, at doses that caused AHR in
response to vagal stimulation, the OPs CPF, PTH, and DZN
did not potentiate bronchoconstriction induced by intrave-
nously administered acetylcholine in vagotomized guinea pigs
(83, 141). Importantly, across all experimental conditions (ve-
hicle, OP exposed, and eserine exposed), vagally mediated
bronchoconstriction was frequency dependent and blocked
by atropine, indicating that bronchoconstriction was mediated
by release of acetylcholine from prejunctional nerves onto
postjunctional M3 receptors on airway smooth muscle. Collec-
tively, these studies provide proof-of-concept evidence that at
levels such as might be encountered in occupational or resi-
dential settings OPs could feasibly contribute to asthma patho-
genesis or exacerbation of asthmatic symptoms. The observa-
tion that these OPs induced AHR independent of AChE inhi-
bition is of significant importance for risk assessments, because
many regulatory agencies, including the US Environmental
Protection Agency and the US Occupational Safety and Health
Administration, use AChE inhibition as a point of departure for
determining safe levels of OPs.
NEURAL MECHANISMS OF OP-INDUCED AHR
The vagus nerves provide the dominant autonomic and
sensory control of airway smooth muscle tone and reactivity
(28). Preganglionic parasympathetic nerve fibers within the
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vagus nerves synapse onto postganglionic parasympathetic
nerve cell bodies clustered within the airways (Fig. 1A). Re-
lease of acetylcholine from postganglionic parasympathetic
nerves causes bronchoconstriction by activating M3 musca-
rinic receptors on airway smooth muscle. However, acetylcho-
line also binds to autoinhibitory M2 muscarinic receptors on
the postganglionic, prejunctional parasympathetic nerves (71,
84), which decreases further release of acetylcholine, thereby
limiting vagally induced bronchoconstriction (Fig. 1B). The
physiological importance of autoinhibitory M2 receptors was
clearly established by demonstrating that M2-selective antag-
onists, such as gallamine and methoctramine, increased, by as
much as 10-fold, bronchoconstriction in response to electrical
stimulation of the vagus nerves (84) and reflex bronchocon-
striction induced by histamine (45). The autoinhibitory func-
tion of prejunctional M2 receptors, which was first described in
guinea pig lung (84), has since been demonstrated in auto-
nomic target organs of all species studied thus far (205),
including humans (161, 162).
A significant body of literature provides evidence that OPs
can interfere with the function of muscarinic receptors inde-
pendent of AChE inhibition via direct interactions with recep-
tors or modulation of downstream signaling pathways (re-
viewed in Refs. 124, 179; see Table 2). The outcome of these
interactions (potentiation or blockade of receptor function)
varies according to the OP, the muscarinic receptor subtype,
and the target cell. This extensive literature suggests that OPs
may induce AHR either by potentiating M3 receptor activity in
airway smooth muscle or by blocking autoinhibitory M2 re-
ceptors on airway parasympathetic nerves. These hypotheses
have been tested in the guinea pig model of OP-induced AHR
using methacholine, a nonspecific muscarinic receptor agonist
that activates postsynaptic M3 receptors on airway smooth
muscle to cause bronchoconstriction, and pilocarpine, a mus-
carinic agonist with 100-fold selectivity for prejunctional M2
vs. postjunctional M3 receptors (84, 137) that binds neuronal
M2 receptors to attenuate vagally induced bronchoconstriction
in control animals (83, 141). At doses that caused AHR in the
absence of significant AChE inhibition, CPF, DZN, and PTH
had no effect on methacholine-induced bronchoconstriction
24 h after OP exposure. These data suggest that OP-induced
AHR at this time point is not due to changes in either post-
Fig. 1. Innervation of the conducting airways. A:
airway smooth muscle (ASM) contraction is directly
controlled by vagal parasympathetic nerves (blue)
arising from the brain stem in the central nervous
system (CNS). These nerves synapse onto postgan-
glionic parasympathetic neurons that supply ASM
(pink). Blood vessels (red) and submucosal glands
(yellow) are also innervated by postganglionic para-
sympathetic nerves. Sympathetic nerves (purple)
innervate blood vessels and submucosal glands and
synapse onto postganglionic parasympathetic fibers.
In some nonhuman species, sympathetic nerves also
directly innervate ASM. Sensory C fibers arising
from dorsal root ganglia (DRG) (green) innervate
the ASM, epithelium, and submucosal glands. B: at
parasympathetic-ASM junctions, muscle contrac-
tion is mediated by ACh (black rectangles) released
from the postganglionic nerves. ACh binding to
postjunctional M3 muscarinic receptors (green)
causes ASM contraction. Cholinergic signaling is
terminated by enzymatic cleavage of ACh by ace-
tylcholinesterase (orange) and by ACh binding to
prejunctional autoregulatory M2 muscarinic recep-
tors (red) expressed by postganglionic parasympa-
thetic nerves that inhibit further release of ACh.
Table 2. Experimental evidence of OP-induced muscarinic receptor dysfunction
OP Model Exposure Paradigm Key Findings Reference
Sarin Rat Inhalation, 0.2 or 0.4 mg/m3 for 1 h/day; 1, 5,
or 10 days
2M1 and M3 receptor densities in multiple brain
regions when exposed during heat stress
(103)
CPF/CPO Neonatal rat Oral 1.5 or 3 mg·kg1·day1 CPF, 0.25 or 0.35
mg·kg1·day1 CPO; PND 1–6
2Forebrain mAChR density by CPF but not
CPO
(18, 19)
CPF Guinea pig sc, 70 or 390 mg/kg 1AHR via neuronal M2 receptor dysfunction (83)
PTH, DZN Guinea pig sc, 1–10 mg/kg PTH, 0.75–75 mg/kg DZN 1AHR via neuronal M2 receptor dysfunction (141)
CPF/CPO,
PTH/PO
In vitro protein preparation CPO IC50 70 M 2GRK2 phosphorylation of M2 by CPF/CPO but
not PTH/PO
(256)
CPO Primary neuronal cell
culture
100 M 1Agonist-stimulated M2 internalization (225)
AHR, airway hyperreactivity; CPF, chlorpyrifos; CPO, chlorpyrifos-oxon; DZN, diazinon; GRK2, G protein-coupled receptor kinase-2; mAChR, muscarinic
acetylcholine receptor; OP, organophosphorus pesticide; PO, paraoxon; PND, postnatal day; PTH, parathion.
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synaptic M3 receptors or airway smooth muscle contractility.
In contrast, pilocarpine dose-response curves were shifted
significantly to the right in OP-exposed animals relative to
vehicle control animals, demonstrating decreased responsive-
ness of neuronal M2 receptors at 24 h after exposure. Impor-
tantly, at doses that did not decrease M2 receptor function OPs
also did not cause AHR.
Interestingly, OP blockade of M2 receptors appears to be
relatively specific to neuronal autoinhibitory receptors since
the function of cardiac postjunctional M2 receptors was not
altered in OP-exposed guinea pigs (83, 141). Furthermore,
there was no evidence of effects on other organ systems
predominantly controlled by muscarinic neurotransmission
(e.g., pupils, salivary glands, gut). The biological reason(s) as
to why the lung appears to be uniquely susceptible to OPs after
systemic exposure to doses that do not cause cholinergic crisis
is not known. However, these observations are consistent with
literature suggesting that regulation of M2 receptors (17, 81,
136) and the effects of OPs on muscarinic receptors (50, 123,
215, 225, 243) vary with tissue and cell type.
These data support a model in which low-level OPs cause
AHR by interfering with negative-feedback control of cholin-
ergic signaling in parasympathetic nerves, thereby potentiating
vagally induced bronchoconstriction. Resting cholinergic tone
(163), reflex bronchoconstriction triggered by lung irritation
(32, 227), and mucin secretion in the airways (187, 196) are
also regulated by postganglionic parasympathetic nerves. Thus
it seems likely that OPs also potentiate these physiological
processes, which would be consistent with the hypothesis that
OPs cause and/or exacerbate asthma. Although it has yet to be
determined whether OPs cause neuronal M2 receptor dysfunc-
tion in the airways of species other than the guinea pig, the
potential relevance of this model to human asthma is strongly
supported by clinical studies demonstrating that neuronal M2
receptors are dysfunctional in the airways of asthmatic patients
(10, 162). Additional questions that have yet to be systemati-
cally addressed are the persistence of OP effects on AHR—
currently it has been shown that CPF-induced AHR persists for
at least 7 days after a single injection in the guinea pig model
(141)—and whether the mechanism of OP-induced AHR
changes at varying times after exposure. The latter is relevant
given experimental data demonstrating that the mechanism of
ozone-induced AHR shifts from increased acetylcholine re-
lease as a result of M2 dysfunction at 1 day after exposure to
increased substance P (SP) release coupled with airway smooth
muscle hyperreactivity at 3 days after exposure (251).
The mechanism(s) by which OPs block neuronal M2 mus-
carinic receptor function in airways currently is not well
understood. Initial efforts to address this question tested the
hypothesis that OPs interact directly with airway nerves to
pharmacologically antagonize M2 receptor function or down-
regulate M2 receptor expression (183), analogous to OP effects
on muscarinic receptors in the brain (reviewed in Refs. 124,
179). However, several lines of experimental evidence argue
against a significant role for these mechanisms in OP-induced
AHR: 1) Neither PTH nor its oxon metabolite, paraoxon (PO),
altered vagally induced bronchoconstriction in guinea pigs or
isolated trachea when administered acutely at levels that did
not inhibit AChE. 2) Neither PTH nor PO downregulated
transcript levels of M2 receptors in human neuroblastoma cells
or primary guinea pig parasympathetic nerve cultures. 3) Nei-
ther PTH nor PO decreased protein levels or inhibited carba-
chol-induced internalization of M2 receptors in primary auto-
nomic neurons or COS cells transfected with cDNA encoding
full-length human M2 receptor (183). Whereas the effect of
low-level OP exposures on M2 receptor expression or ligand
binding to neuronal M2 receptors in the intact lung has yet to
be determined, collectively the published data support an
alternative model in which OPs directly target intermediary
cell type(s), which in turn release factors that act on parasym-
pathetic nerves to cause neuronal M2 muscarinic receptor
dysfunction and AHR. This proposed model of an indirect
effect of OPs on neuronal M2 receptors in airways would be
consistent with the growing evidence of noncholinergic mech-
anisms of OP neurotoxicity (43, 124, 179).
INFLAMMATORY MECHANISMS OF OP-INDUCED AHR
A key characteristic of asthma is lung inflammation. Type 2
(TH2) immune responses, which are classically associated with
allergy, play a predominant role in human asthma (reviewed in
Refs. 70, 91). Type 2 immunity is largely regulated by IL-1,
IL-5, and IL-13 secreted by TH2 cells and is characterized by
high IgE titers and eosinophilia (6). There is a strong relation-
ship between airway eosinophilia and atopic asthma (11, 23,
52, 59, 78). The numbers of eosinophils in lung tissue, and
levels of eosinophil cationic protein in bronchoalveolar lavage,
are significantly increased in patients with atopic asthma (4,
129). Severe asthma is also associated with the presence of an
increased and persistent population of eosinophils in the lungs,
even in the absence of acute exacerbation (237). In a guinea pig
model of antigen-induced AHR, antigen sensitization, without
challenge, has been shown to recruit eosinophils to the lungs
and cause them to cluster around airway nerves (47, 65), a
phenomenon also observed in human asthma (47). Blocking
eosinophil influx with antibodies to either IL-5 (65) or VLA-4
(80) or inhibiting eosinophil migration to the nerves with low
doses of dexamethasone (69) prevents AHR and neuronal M2
receptor dysfunction in antigen-challenged guinea pigs. The
mechanism by which eosinophils block neuronal M2 receptor
activity involves release of major basic protein (MBP) from
eosinophils activated by antigen challenge (46, 47) or viral
infection (1, 2). MBP acts as an allosteric inhibitor of the
neuronal M2 receptors (121), thereby potentiating vagally
stimulated bronchoconstriction. Antibody blockade of MBP
protects M2 function and inhibits AHR (68), and removal of
MBP from M2 receptors by heparin acutely restores M2
receptor function and reverses AHR (82) in a guinea pig model
of antigen-induced AHR.
Low-level OP exposures have been observed to influence
allergic disease in experimental models. Specifically, OPs were
shown to enhance immune responses to other chemical aller-
gens in the local lymph node assay (86, 87) and to exacerbate
eosinophilia in a mouse model of ovalbumin-induced allergic
airway inflammation (169). However, preclinical evaluations
in guinea pigs have not yielded a clear answer regarding the
role of eosinophils in OP-induced AHR. In support of a role for
eosinophils in OP-induced AHR, pretreatment with function-
blocking antibody to IL-5 prevented OP-induced AHR in
sensitized guinea pigs exposed to PTH (182) or CPF (180).
However, neither OP increased the number of eosinophils in
airways or associated with airway nerves or stimulated release
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of MBP from eosinophils in airways. Moreover, although IL-5
antibody decreased eosinophils and MBP in the airways of
sensitized animals exposed to vehicle, it had no effect on these
end points in sensitized animals exposed to either CPF or PTH.
Interestingly, IL-5 antibody decreased MBP in the trachea of
sensitized animals exposed to CPF, but heparin did not reverse
CPF-induced AHR (180). There are at least two possible
interpretations of these data: 1) eosinophils mediate CPF- and
PTH-induced AHR in sensitized animals, but these OPs trigger
eosinophils to release mediators other than MBP to cause
AHR, or 2) IL-5 antibody prevents OP-induced AHR in sen-
sitized animals via eosinophil-independent mechanism(s). Dis-
tinguishing between these possibilities has yet to be addressed
experimentally; however, in support of the latter, IL-5 recep-
tors are expressed by airway smooth muscle (189) and other
inflammatory cells found in the lungs (55, 177).
In contrast to its significant block of OP-induced AHR in
sensitized animals exposed to CPF or PTH, IL-5 antibody had
no effect on AHR in sensitized animals exposed to DZN (180),
consistent with the observation that DZN-induced AHR was
not altered by sensitization. Pretreatment with IL-5 antibody
also had no effect on CPF- or PTH-induced AHR in nonsen-
sitized guinea pigs (180, 182). These data indicate that IL-5-
independent mechanisms, and thus presumably eosinophil-
independent mechanisms, mediate DZN-induced AHR and the
effects of CPF and PTH on AHR and M2 receptor dysfunction
in nonsensitized animals. A similar switch in mechanism
depending upon sensitization status has been observed in
preclinical models of virus-induced AHR (2). These findings
have significant translational implications for predicting phys-
iological responses of individuals exposed to low-level OP
exposures and for designing individualized therapeutic inter-
ventions. They also raise the question of whether inflammatory
mechanisms mediate OP-induced AHR in nonsensitized indi-
viduals. Inflammatory cell types other than eosinophils that are
resident in the lungs, including macrophages, mast cells, and
neutrophils, have been implicated in AHR triggered by other
stimuli (74), including viral infection (138) and ozone expo-
sure (250). It is also known that proinflammatory cytokines
such as IFN-, TNF-, and IL-1 can decrease in vivo neu-
ronal M2 receptor expression and function in airways (122,
168, 230).
Evidence from diverse experimental models demonstrates
that low-level OP exposure can activate many of the inflam-
matory mediators implicated in AHR (reviewed in Ref. 13; see
Table 3). For example, inhalation of the OP nerve agent sarin
triggers a robust inflammatory response in the lungs of guinea
pigs (142) and rats (176), measured as significantly increased
levels of inflammatory mediators, including histamine and
prostaglandins, increased numbers of inflammatory cells, spe-
cifically eosinophils and macrophages, and increased mRNA
expression for proinflammatory cytokines, such as IL-1, IL-6,
and TNF-. In the rat brain, low levels of sarin were observed
to increase gene expression of TNF-, IL-1, and IL-6, coin-
cident with decreased expression of M1 muscarinic receptors
(103). Similarly, low-level CPF exposure increased expression
of TNF- and IL-1 in mouse brain (108). Ex vivo exposure to
the OP malathion (MAL) activated mouse macrophages (193–
195) and potentiated macrophage phagocytosis (75). In vivo
exposure to low-level MAL stimulated mast cell degranu-
lation in the intestine and skin (192), whereas ex vivo MAL
exposure triggered histamine release from mast cells (190)
and basophils (242). Studies of neutrophil activity in OP-
exposed workers suggested that OPs may decrease neutro-
phil chemotaxis (104), although ex vivo CPF exposure of
human whole blood cultures containing neutrophils and
other inflammatory cells potentiated LPS-induced release of
IFN- (60). The molecular mechanisms by which OPs
activate immune cells remain largely unknown. There is
evidence that OPs trigger nonneuronal cholinergic signaling
of inflammatory cells (90, 144, 220), and mechanisms in-
volving activation of signaling pathways by OP metabolites
as well as OP-induced cytotoxicity/cell death of immune
cells have also been implicated (56).
Collectively, these observations provide biological plausi-
bility for the hypothesis that OPs induce AHR by increasing
Table 3. Experimental evidence of OP-induced inflammation and immune modulation
OP Model Exposure Paradigm Key Findings Reference
Multiple Occupationally exposed human
serum
na 1Incidence of upper respiratory infections in
applicators, 2serum neutrophil chemotaxis
(104)
MAL Mouse Oral; chronic 0.1–100 mg·kg1·day1, 14 days
acute 450–600 mg/kg
1Macrophage activity and mast cell
degranulation
(191,193)
CPF Rat Oral; 10 or 25 mg/kg Systemic 1 in TNF- and core body
temperature
(198)
Sarin Rat Inhalation; 0.2 or 0.4 mg/m3 for 1 h/day; 1, 5
or 10 days
1Expression of IL-1, TNF-, IL-6 mRNA
in brain
(103)
CPF Primary human fetal astrocytes 25 M; 7 days 1Transcripts of IL-6, GFAP, MAPK (158)
BRP Mouse, dermal challenge and
LLNA
Dermal sensitization (0.3%); dermal or
intrathecal challenge (0.03 or 0.003%);
LLNA 0.1–3%
1Inflammatory cells and IFN- (87)
PTH Mouse, LLNA Oral; 0.4–1.2 mg/kg 1Allergic potential of environmental
allergens; 1TH1 cytokines
(86)
PTH Mouse OVA allergic
inflammation model
Oral; 0.15 or 15 mg·kg1·day1, 5 days Exacerbated allergic inflammation; 1IgE,
cytokines, chemokines, and eosinophilia
(169)
CPF, methyl-
PTH
HepG2 cells 2–8 M, 24–72 h 2PON1 mRNA and protein, increased
inflammatory cytokines
(157)
CPF/CPO Human blood in vitro 1–1,000 g/ml CPO 1IFN- response to LPS (60)
BRP, bromofos; CPF, chlorpyrifos; CPO, chlorpyrifos-oxon; GFAP, glial fibrillary acidic protein; LLNA, local lymph node assay; MAL, malathion; na, not
applicable; OP, organophosphorus pesticide; OVA, ovalbumin; PON1, paraoxonase 1; PTH, parathion.
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inflammatory cytokines in the airways via stimulation of resi-
dent inflammatory cells other than eosinophils. In support of
this hypothesis, recent studies have demonstrated that macro-
phages are required for OP-induced AHR in nonsensitized
animals. Pretreatment with liposome-encapsulated clodronate
induced alveolar macrophage apoptosis and prevented AHR in
nonsensitized guinea pigs exposed to PTH (181). Transcripts
for TNF- and IL-1 were upregulated in alveolar macro-
phages isolated from PTH-treated guinea pig lungs, and al-
though ex vivo exposure to PTH did not significantly increase
IL-1 and TNF- mRNA, it did increase TNF- protein
release from alveolar macrophages isolated from the lungs of
naive guinea pigs. Consistent with these observations, pretreat-
ment with the TNF- inhibitor etanercept, but not the IL-1
receptor inhibitor anakinra, prevented PTH-induced AHR and
protected neuronal M2 receptor function in the airways of
PTH-exposed guinea pigs (181). These data are consistent with
a model in which low-level OPs activate macrophages to
release TNF-, which causes M2 receptor dysfunction and
AHR. However, the results from these studies also raise sig-
nificant questions regarding the mechanistic relationship be-
tween OPs, macrophages, TNF-, and parasympathetic nerves
that lead to AHR, e.g., what is the cellular origin of TNF-,
and what factor(s) mediates increased TNF- expression in
alveolar macrophages in vivo? OP activation of macrophages
in vivo may occur indirectly via activation of mast cells or
upregulation of prostaglandins, since depletion of the former or
blockade of the latter prevented MAL-induced macrophage
activation in mice (191). The published data also do not rule
out potential roles for other inflammatory mediators known to
be influenced by OPs, such as IFN-.
OXIDATIVE STRESS AS A POTENTIAL MEDIATOR OF
OP-INDUCED AHR
Oxidative stress plays an important role in the pathogenesis
of asthma (reviewed in Refs. 39, 184, 200). Oxidative stress
occurs when the production of reactive oxygen species (ROS)
and reactive nitrogen species (RNS) exceeds the antioxidant
capacity of the system. This imbalance can lead to oxidative
and nitrative damage to macromolecules, which in turn can
cause cell damage and elicit robust inflammatory responses
(22). Tight control of ROS and RNS is essential for maintain-
ing lung homeostasis, as indicated by observations that the
redox system in the asthmatic lung is clearly unbalanced
toward an oxidative state (41). This is likely due in part to the
observation that resident and recruited immune cells in the
asthmatic lung produce excess ROS and RNS (61). Preclinical
studies have demonstrated that ROS directly triggers airway
smooth muscle contraction (224) and causes a shift from a TH1
to a TH2 immune response (167). Higher levels of reactive
molecules, such as nitric oxide, are associated with increased
risk and severity of asthma, and fractional exhaled nitric oxide
is used as a marker of TH2 inflammation to confirm atopic
asthma and to diagnose cough-variant asthma and eosinophilic
bronchitis (214, 232). Asthma is also associated with decreased
levels of endogenous antioxidant molecules, both enzymatic, such
as superoxide dismutase and catalase, and nonenzymatic, such as
glutathione and vitamin E (41, 239). Evidence for the latter is the
association between decreased glutathione levels in exhaled
breath condensate and asthma exacerbation in children (42).
Relatively low levels of OPs have been shown to induce
oxidative stress in a variety of experimental models (Table 4).
Of particular relevance to OP-induced AHR: 1) CPF was
Table 4. Experimental evidence of OP-induced oxidative stress
OP Model Exposure Paradigm Key Findings Reference
Multiple Occupational exposure na 1Malondialdehyde (antioxidant enzyme) levels and
bronchial obstruction
(132)
CPF Human monocyte cell line
U937
4.45–570 M, 0.5–24 h 1Time- and concentration-dependent apoptosis mediated
by caspase activation (caspase 3)
(164)
Multiple Occupational exposure na 1Urinary and leukocyte 8-OHdG levels during spraying,
correlated with urinary metabolite levels
(139)
CPF, dichlorvos Human natural killer cell lines 0–100 ppm, 1–72 h 1Time- and concentration-dependent apoptosis mediated
by caspase activation (caspase 3)
(145)
CPF Oligodendrocyte progenitor
cells
3.9–250 M, 24–72 h 1Oxidative stress and caspase activation (203)
Multiple Occupational exposure na 1Oxidative stress and DNA damage, higher in
applicators, same in cultured lymphocytes
(135)
CPO Human and mouse
neuroprogenitor cell lines
0.001–100 M 2Proliferation in human cells, increased caspase 3
activation in mouse cells
(49)
CPF Mouse Oral; 3–12 mg/kg 1Oxidative damage in hepatic and renal tissue (ROS,
DNA-protein cross-linking, 8-OHdG, malondialdehyde,
2glutathione)
(153)
PTH/PO,
MAL/MO
Primary cultured human
airway epithelium cells
0.25–10 mM, 24 h 1Oxon metabolites produced dose-dependent
cytotoxicity
(5)
PO EL4 cells 10 nM, 0–16 h 1Apoptosis via ER and mitochondrial mechanisms,
mediated by calcium
(143)
CPF, methyl-PTH HepG2 cells 2–8 M, 24–72 h 2PON1 mRNA, increased inflammatory cytokines (157)
DZN Tilapia 0.97–3.95 ppm, 12 or 24 h 1Oxidative damage to proteins in liver and gills (221)
CPF Occupational exposure Average exposure
estimated at 3.7
g·kg1·day1
1In urinary 8-OHdG 1 day after spraying, returning to
baseline after 2 days; marker for ox stress to DNA
(231)
CPF, chlorpyrifos; CPO, chlorpyrifos-oxon; DZN, diazinon; ER, endoplasmic reticulum; MAL, malathion; MO, maloxon; na, not applicable; 8-OHdG,
8-hydroxydeoxyguanosine; OP, organophosphorus pesticide; PTH, parathion; PO, paraoxon; PON1, paraoxonase 1; ROS, reactive oxygen species.
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observed to trigger rapid and reversible, concentration-depen-
dent production of ROS in differentiated PC12 cells, a neuro-
nal cell line used to model autonomic neurons, and CPF
sensitized PC12 cells to other prooxidant stressors (48); 2) ex
vivo exposure to MAL stimulated ROS generation in macro-
phages (194, 195); and 3) epidemiologic studies of pesticide
workers identified an association between occupational OP
exposure and biomarkers of oxidative stress (132, 135, 139,
207, 231). A major question in the field of OP neurotoxicology
is whether oxidative stress mediates the neurotoxic effects of
OPs. A 2009 review of the human and animal literature
concluded that oxidative stress does contribute to chronic OP
neurotoxicity (213). This conclusion was based on evidence of
increased levels of protein nitration and lipid peroxidation,
decreased total antioxidant capacity, and protective effects of
antioxidants against OP-mediated histopathological and bio-
chemical alterations. Thus there is strong experimental evi-
dence linking OPs to oxidative stress and data to support the
hypothesis that oxidative stress mediates OP neurotoxicity.
It remains controversial, however, as to whether OPs can
induce oxidative stress in the absence of significant AChE
inhibition. Experimental evidence clearly demonstrates that
acute AChE inhibition is associated with oxidative stress in the
brain (146, 159) and that increased oxidative stress may con-
tribute to (159) or exacerbate (148) cholinergic toxicity elicited
by acute OP inhibition of AChE. However, in vitro studies
demonstrate that OP-induced oxidative stress is antagonized by
coexposure to antioxidants but not cholinergic antagonists
(92), suggesting that AChE inhibition is not required for
OP-induced oxidative stress. In at least one study of pesticide
workers (207), increased levels of antioxidant enzymes and
lipid peroxidation in blood leukocytes and erythrocytes were
observed in the absence of blood cholinesterase inhibition,
providing further evidence that OPs may induce oxidative
stress independent of AChE inhibition. Such observations raise
the question, however, of how OPs increase ROS/RNS pro-
duction in the absence of significant AChE inhibition. It has
been posited that ROS formed during cytochrome P-450-
mediated metabolism of OPs predisposes toward an oxidative
environment that evolves into a positive feedforward cycle of
inflammation and oxidative stress (152). Since cytochrome
P-450 enzymes involved in OP metabolism are expressed in
the lung (94), this suggests the novel hypothesis that pulmo-
nary metabolism of OPs creates a local prooxidant environ-
ment that promotes asthma or exacerbation of asthmatic symp-
toms. The more immediate data gap, however, is that although
there is experimental evidence to support the plausibility of
oxidative stress as a mechanism underlying OP-induced AHR,
to date there are no studies that have directly tested this
hypothesis.
MECHANISMS OF NEURONAL PLASTICITY AS MEDIATORS
OF OP-INDUCED AHR
Neuronal plasticity is a key characteristic of a functional
nervous system that enables fully differentiated, postmitotic
neurons to adapt to changing environmental stimuli. Neuronal
plasticity can be broadly categorized as changes in neuronal
structure or morphology and changes in neurochemical prop-
erties. Both types of neuronal plasticity have been implicated
in the pathogenesis of AHR in preclinical models. For instance,
hyperinnervation in the lung has been linked to AHR in a
murine model of early life allergen exposure (9) and in a
nonhuman primate model of early life allergen and ozone
exposure (127). In guinea pigs, increased dendritic arborization
of neurons in postganglionic parasympathetic neurons corre-
lated with increased excitability of lower airway parasympa-
thetic nerves (101). Collectively, these studies suggest that
structural changes in pulmonary nerves may contribute to
AHR. Neurochemical changes, and in particular increased
expression of tachykinins such as SP, have also been linked to
AHR (67, 229, 241).
Neurotrophins play a key role in modulating neuroplasticity
in the peripheral nervous system. Neurotrophins, which include
nerve growth factor (NGF), brain-derived neurotrophic factor
(BDNF), neurotrophin-3, and neurotrophin-4/5, are critically
involved in nervous system development and maintenance,
influencing neuronal cell survival, differentiation, and target
innervation (8, 21, 37, 40, 117, 199). Many studies have shown
that neurotrophins, particularly NGF, contribute to AHR by
altering cholinergic and/or sensory innervation in the airways
(12, 24, 38, 53, 101, 119, 171, 173, 246). For example, NGF
can increase expression of neuropeptides, such as SP, calci-
tonin gene-related peptide (CGRP), and neurokinin A, in sen-
sory nerve fibers in the lung; increased levels of these neuro-
peptides can increase smooth muscle contraction via direct
action on airway smooth muscle or indirectly via action on
cholinergic nerve fibers (15, 29, 30, 51, 126, 154). NGF has
also been shown to cause a phenotypic switch in sensory
neurons innervating the trachea in the guinea pig, resulting in
more cells expressing SP (120), and in the mouse NGF directly
affects synaptic transmission in airway parasympathetic nerves
(233).
Neurotrophins and their receptors are also expressed by
many immune cell types, including macrophages and mast
cells (165, 228), as well as by airway smooth muscle and
airway epithelium during inflammatory events (38, 77). Addi-
tionally, eosinophils clustered around airway nerves in preclin-
ical asthma models can increase expression of NGF and neu-
ropeptides, contributing to airway hyperresponsiveness (59).
The connection between inflammation and neuroplasticity is
evident in a number of in vivo and in vitro systems. For
example, ovalbumin sensitization in the guinea pig, a widely
used model of allergic inflammation, increases excitability of
vagal sensory nerves (147, 149, 253). The proinflammatory
cytokines TNF- and IL-1 have been shown to increase
expression and release of neurotrophins in many in vitro
preparations, including human monocytes (204), human and
mouse pulmonary epithelial cells (76, 97), human bronchial
smooth muscle cells (130), and rat astrocytes (88). Further-
more, IL-1 has been shown to induce NGF expression leading
to AHR in both in vivo (229) and ex vivo (79) models. In
addition to effects on neurochemistry, proinflammatory cyto-
kines have been shown to modulate neuronal cytoarchitecture
in autonomic neurons (95, 134).
Thus neuroimmune cross talk has proven to be important in
airway physiology, especially in disease states (77, 93, 150,
165, 217). When this neuroimmune cross talk results in a
positive feedback loop to further increase release of proinflam-
matory neuropeptides, it is classified as neurogenic inflamma-
tion. Neurotrophins have been shown to play a role in neuro-
genic inflammation and AHR, and bronchoalveolar lavage
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fluid levels of neurotrophins were found to positively correlate
with asthma severity in children (216). Most notably, early life
allergen exposure has been shown to result in persistent AHR
and altered neuropeptide expression in several animal models
(9, 24, 38, 77, 93, 127), with some of these studies directly
implicating neurotrophin-dependent mechanisms (9, 24, 38).
OPs have several well-documented direct effects on both
morphological and neurochemical plasticity of peripheral neu-
rons (Table 5). At levels that do not inhibit the enzymatic
activity of AChE, CPF promotes dendritic growth but inhibits
axonal growth in sympathetic neurons cultured from rat supe-
rior cervical ganglia (116). Low levels of CPF also inhibit
axonal growth in sensory neurons cultured from rat dorsal root
ganglia (244) and neurite outgrowth in neuronal PC12 cells
(209), while the oxon metabolite of CPF inhibits axonal growth
of sensory neurons in developing zebrafish (245). Determining
whether and how OPs affect the morphology of nerves that
innervate airways and how such changes might influence AHR
is an important area of future research. A number of neuro-
chemical changes have also been described after OP exposure.
OPs upregulate SP expression in the brain (170), and CPF and
DZN alter transcriptional profiles of genes related to neu-
rotransmitter phenotype differentiation in PC12 cells (208,
210, 212). OPs also affect a number of factors known to
modulate neuronal plasticity. Preclinical models of low-dose
chronic OP exposure have reported that OPs alter the expres-
sion of the neurotrophins NGF and BDNF in the brain (18–20,
140, 211, 219). DZN has been shown to alter transcriptional
profiles of neurotrophic factors (208, 212) and to change the
neurotransmitter phenotype of PC12 cells (210). However,
whether low-level OP exposures alters expression or function
of neurotrophins in the periphery remains an understudied
question. Also not known is whether OPs upregulate SP or
CGRP in the airways or alter vagal or dorsal root ganglion
nociceptors.
Although OPs have not yet been directly implicated in
neurogenic inflammation in the airways, it seems like a logical
line of inquiry given their known effects on inflammation and
neuronal signaling (Table 3, Table 5). A testable hypothesis
derived from these observations is that OP-induced inflamma-
tion alters NGF levels in the lung leading to changes in
innervation and, subsequently, AHR (Fig. 2). Although it is
unlikely that OP-induced changes in neurotrophin expression
or action mediate effects of OPs on AHR 24 h after exposure,
this mechanism could feasibly contribute to persistent effects
of OPs on AHR. Convergence of OP effects on neurogenic
inflammation and neuroplasticity could also be particularly
significant in the context of developmental OP exposure. The
developing lung is especially susceptible to environmental
insult (178), and developmental exposure to other environmen-
tal contaminants has been shown to permanently affect pulmo-
nary innervation in preclinical models (9, 240, 241, 252).
CONCLUSIONS
Both epidemiologic and clinical studies have linked expo-
sures to occupational (73, 105, 109–111, 113, 114, 166, 172,
175) and environmental (156, 185, 186, 249) levels of OPs to
increased incidence of asthma. Preclinical studies demonstrate
that diethyl phosphorothioate OPs trigger AHR at doses that do
not significantly inhibit AChE (83, 141), corroborating a causal
relationship between low-level OPs and asthma. The working
model of OP-induced AHR derived from the existing mecha-
nistic data is that OPs cause dysfunction of autoinhibitory M2
muscarinic receptors expressed on postganglionic parasympa-
thetic nerves in the airways (83, 141). Dysfunction of these
neuronal M2 receptors results in increased release of acetyl-
choline in response to nerve stimulation, thereby increasing
cholinergic drive on M3 muscarinic receptors expressed by
airway smooth muscle. OP effects on neuronal M2 receptors
appear to be mediated indirectly (183) via OP modulation of
immune cells resident in the lung (180–182). There remain
outstanding data gaps in this model, including 1) the identity
and cause-effect relationship(s) between inflammatory cells,
soluble mediators, and neuronal M2 muscarinic receptors in
the airways; 2) whether the mechanism(s) of OP-induced AHR
Table 5. Experimental evidence of OP effects on neuroplasticity
OP Model Exposure Paradigm Key Findings Reference
PTH, FEN Chick DRG explant 1 M, 72 h 2Cell membrane integrity; retraction of pseudopodia,
induction of lipid vacuoles, lipid accumulation,
disruption of tubular structures in growth cone
(223)
CPF/CPO Neonatal rat Oral; 1.5 or 3 mg·kg1·day1 CPF, 0.25 or
0.35 mg·kg1·day1 CPO, PND 1–6
CPF but not CPO 2forebrain NGF expression (18, 19)
CPF/CPO Rat SCG primary neuronal
cell culture
0.001–1 M CPF, 0.001–1 nM CPO 2Axonal outgrowth but enhanced BMP-induced
dendritic growth
(116)
CPF, Methyl-
PTH
Neonatal rat Oral, 4 or 6 mg/kg CPF, 0.6 or 0.9 mg/kg
methyl-PTH, PND 10–20
1NGF and BDNF expression in multiple brain
regions; 1marker of neuronal activity in
hippocampus and cortex
(20)
CPF, DZN Neonatal rat sc, 1 mg/kg CPF, 1 or 2 mg/kg DZN, PND
1–4
2Transcripts of neurotrophic growth factors in the
FGF family in multiple brain regions
(211)
CPF Rat sc, 2.5–18 mg/kg, every other day for 30
days
2NGF expression in multiple brain regions, 2in
axonal transport in sciatic nerves ex vivo
(219)
CPF/CPO Rat DRG primary
neuronal cell culture
0.001–10 M CPF, 0.001–10 nM CPO,
24 h
2Axonal outgrowth (244)
CPF/CPO Zebrafish 0.003–1 M, 24–72 h CPO but not CPF 2axonal growth of sensory neurons
and motor neurons and affected swimming behavior
(245)
BDNF, brain-derived neurotrophic factor; BMP, bone morphogenetic protein; CPF, chlorpyrifos; CPO, chlorpyrifos-oxon; DRG, dorsal root ganglion; DZN,
diazinon; FEN, fenthion; FGF, fibroblast growth factor; NGF, nerve growth factor; OP, organophosphorus pesticide; PND, postnatal day; PTH, parathion; SCG,
superior cervical ganglia.
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change with time after exposure; and 3) how they change with
sensitization status. Given the significant overlap between
mechanisms of OP neurotoxicity elucidated for target organs
other than the lung and mechanisms of AHR in asthma, it
seems likely that multiple mechanisms of OP neurotoxicity,
including inflammation, oxidative stress, and neuronal plastic-
ity, are involved in OP-induced AHR. Thus focusing on the
interplay between these processes in future preclinical studies
may provide important mechanistic insights, which in turn will
inform epidemiologic studies as well as preventive or thera-
peutic measures.
Significant questions also remain regarding clinical aspects
of OP-induced AHR. How long after a single exposure does
OP-induced AHR persist? Do OPs other than the diethyl
phosphorothioate OPs cause AHR? What factors in addition to
atopy (180–182) influence respiratory responses to OPs—do
sex, age, specific gene mutations, and polymorphisms influ-
ence outcome? But perhaps the most significant data gaps
involve our understanding of whether, and how, developmental
or early life OP exposures contribute to individual risk for
adolescent or adult asthma. Although the epidemiologic evi-
dence suggests that early life exposure to OPs increases the risk
of developing asthma later in life (185, 186), this relationship
has yet to be demonstrated in a preclinical model. Moreover,
the mechanisms by which OPs influence the developing lung to
increase susceptibility to asthma are not obvious from the
current mechanistic understanding of OP-induced AHR. How-
ever, “borrowing” from the literature of OP neurotoxicity,
plausible hypotheses can be derived. First, as discussed above,
OPs can modulate in vitro and in vivo axonal and dendritic
morphogenesis of autonomic and sensory neurons (116, 244,
245). Experimental evidence from preclinical models of
asthma indicates that increased dendritic arborization of post-
ganglionic parasympathetic neurons (101) or increased sensory
innervation of the lung is correlated with AHR (59). Collec-
tively, these data suggest the testable hypothesis that early life
exposures to OPs elicit lasting changes in the morphology of
airway nerves, thereby altering functional patterns of neuronal
connectivity to increase the susceptibility of the lung to AHR.
A second possibility for how developmental OP exposures
might cause persistent asthma derives from literature demon-
strating that OPs can cause epigenetic changes (133, 188, 254,
255).
The reproducible observation that OPs induce AHR inde-
pendent of AChE inhibition in both humans and preclinical
models is of translational significance because many regulatory
agencies, in both the United States and Europe, use peripheral
cholinesterase inhibition as a regulatory point of departure for
OP risk assessments. It is important in this context that current
data indicate that OP-induced AHR may occur at OP levels
below current regulatory thresholds for human health and
safety. A more comprehensive understanding of the mecha-
nisms of OP-induced AHR may provide a scientifically rational
basis for reassessment of safe exposure limits for OPs. Another
important area of future research is the identification of sus-
ceptible subpopulations and understanding how mechanism(s)
of OP-induced AHR vary in different populations. This infor-
mation will be critical for predicting individual physiological
responses to OP exposures and for designing more effective
therapeutic interventions. The evolving literature on OP-in-
duced AHR also raises significant questions regarding the
current use of OP insecticides in the inner cities to control
cockroach antigen (16, 35, 151, 235, 238), which itself is
considered a predominant trigger of asthma (7, 63). Specifi-
cally, these data suggest that exposure to OP insecticides may
be contributing to, rather than ameliorating, asthma.
Fig. 2. Multiple mechanisms of organophosphorus
pesticide (OP) toxicity likely contribute to OP-in-
duced airway hyperreactivity (AHR). Experimental
evidence demonstrates that OPs cause dysfunction
of prejunctional neuronal M2 muscarinic receptors
via TNF--dependent mechanisms (red pathway).
Additional proposed mechanisms of OP-induced
AHR include neurogenic inflammation, oxidative
stress, and altered neuronal plasticity. Although OPs
have been shown to influence these processes in the
central nervous system, OP effects on these pro-
cesses in the periphery have yet to be causally
linked to OP-induced AHR.
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